September 2012
Palay. “The launch of MyCell Services furthers CDI
founder and stem cell pioneer Jamie Thomson’s vision
to enable scientists worldwide to easily access the
power of iPSC technology, thus driving breakthroughs
in human health.”
In addition, CDI, along with the Medical College
of Wisconsin, have received a $6.3 million grant
from the National Heart, Lung, and Blood Institute
(
NHLBI) for a five-year study that “will allow us to
look at a group of 250 patients with
a particular type of heart disease,
Left Ventricular Hypertrophy, and
investigate the mechanism underlying
its genetic background that leads to
heart failure,” says Palay.
CHANGING PERCEPTIONS
In 2011, CDI was recognized by the
Wall Street Journal’s “Technology
SUPPLIER STATS
Visit us online at
onizes Our Approach to Health page 351
